花旗:建滔積層板(1888.HK)暫緩內地上市計劃不會影響產能擴張
花旗發表研究報告表示,建滔積層板(1888.HK)推遲內地A股上市計劃,顯示管理層的目標是保護所有現有股東的利益,為公司治理加分,此舉也表明建滔積層板的自由現金流強勁。該行指公司為中國層壓板╱印刷電路板行業的首選股份,因下半年增速回升,重申其買入投資評級。
報告指,公司原計劃使用A股發行所募資金,建設總成本至少為60億元人民幣的生產設施,但現在將通過銀行貸款進行融資,從長遠來看,暫停上市計劃不太可能損害產能擴張。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.